
    
      Study Type: Interventional Study Design: Randomized, 2-period, 2-sequence, crossover design.

      Official Title: Randomized, 2-Way Crossover, Bioequivalence Study of Galantamine 4 mg Tablet
      and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions.

      Further study details as provided by Actavis Elizabeth LLC:

      Primary Outcome Measures:

      Rate and Extend of Absorption
    
  